Task: Answer the multiple choice question.
Query: Which drug exhibits a 1.273% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] Cc1cc(OCC(O)CN2CCN(CCO)CC2)ccc1C(C)C.Cl
[b] O=C(CCc1nc2sc3c(c2c(=O)[nH]1)CCCC3)NCCOc1ccccc1
[c] CCCNC(=O)c1n[nH]c2c1CC(C(C)(C)CC)CC2
Answer: c. CCCNC(=O)c1n[nH]c2c1CC(C(C)(C)CC)CC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1n[nH]c2c1CC(C(C)(C)CC)CC2
CCCNC(=O)c1n[nH]c2c1CC(C(C)(C)CC)CC2
5-(2-methylbutan-2-yl)-N-propyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide